About Jing Yu Wang
Form D filings for Myrobalan Therapeutics Holding in 2024 list Jing Yu Wang as chief executive officer and director.
Jing Yu Wang first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Jing Yu Wang in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jing Yu Wang works with at each company, as listed on that company's latest Form D.
Myrobalan Therapeutics Holding, Inc. · Form D, Jan 24, 2024